DatasetName,CASKIN2_S(673) CASKIN2_S(842) CASKIN2_S(914) CASKIN2_S(927) CASKIN2_T(929),CASKIN2_S(1135) CASKIN2_S(3) CASKIN2_S(311) CASKIN2_S(314) CASKIN2_S(321) CASKIN2_S(389) CASKIN2_S(393) CASKIN2_S(396) CASKIN2_S(403) CASKIN2_S(406) CASKIN2_S(409) CASKIN2_S(412) CASKIN2_S(471) CASKIN2_S(613) CASKIN2_S(615) CASKIN2_S(618) CASKIN2_S(643) CASKIN2_S(694) CASKIN2_S(695) CASKIN2_S(697) CASKIN2_S(700) CASKIN2_S(705) CASKIN2_S(718) CASKIN2_S(720) CASKIN2_S(725) CASKIN2_S(760) CASKIN2_S(762) CASKIN2_S(776) CASKIN2_S(800) CASKIN2_S(825) CASKIN2_S(855) CASKIN2_S(858) CASKIN2_S(883) CASKIN2_S(946) CASKIN2_T(828) CASKIN2_T(840) CASKIN2_T(841) CASKIN2_T(846) CASKIN2_T(848) CASKIN2_T(907) CASKIN2_T(989) CASKIN2_Y(253) CASKIN2_Y(826)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,0.5029055464260873
FSO2013_Ratio M/L normalized Rep3,,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,0.5069849386423847
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,0.49960381596664877
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,0.5030255473654399
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,0.49919770716522205
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,0.4984123203156394
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,0.5004991826531212
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,0.4990381236330847
RB2022_5_PreEndurance,,0.4983113472466004
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,,0.5095850474529624
WZ2023_Pu_010_30min,0.6582300498063585,0.5140103887571538
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,0.5019920710635156
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,0.5050079533436558
RB2022_8_RecoveryEndurance,,0.5033957081764466
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,0.4974905962638447
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,,0.5001094195805557
PG2020_Intensity 8h_C,,0.47819726392304795
AH2018_SILAC_MR_2_N,,0.5045764094337768
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,0.5008959796188368
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,0.49293274623652317
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,,0.49689892568362987
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,0.500415775990677
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,0.5029327487822944
GF2025_P6_Sph,,0.5056445473173976
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,0.5017038374024596
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.6589377299687693,0.5126737859736945
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,0.5003788872102396
KBE2022_Log2_Ex_34_U,,0.49780735046750246
WZ2023_Pu_005_10min,0.6606421242600135,0.5201076472450129
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.6554892484839727,0.5193457987005811
AH2018_SILAC_MR_2_X,,0.50392093152037
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,0.5013039659129166
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,0.5008388688013955
EJN2021_3_Rest_Basal,,0.4994891839679264
CR2017_Ratio Replicate 1.3,,0.5005067211931543
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,0.5043636111793236
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,0.5017274640624684
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,
AH2018_LFQ_1_C,,0.5068402337491766
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,0.49721990092214946
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.6568580982352819,0.5114461014028027
CK2022_11 40-1,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,0.4999985023564935
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,0.4961157587800715
FSO2013_Ratio H/L normalized Rep2,,
WZ2023_Pu_005_20min,0.6604638751620916,0.5196452967345939
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,0.505439803054402
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,0.5003650428304437
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,0.5034153068406708
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,0.4967815405586409
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,,0.49065740964107757
PG2020_Intensity Mock_10h_D,,0.4940676087181948
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,0.5010414293447145
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,,0.4962970642872953
RCJD2014_5min_1,,0.500386394441713
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,,
PG2020_Intensity 2h_C,,0.49258880051679804
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,0.5026593222512358
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,,0.5010363096941751
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,,0.5038832677425785
CK2022_3 40-1,,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,,0.5013439456052763
HH2022_Reporter intensity 8,,0.5034634148178115
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,0.49523145236271865
EJN2021_5_Rest_Basal,,0.4984097547937301
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,0.5049476786489121
YA2020_Reporter_intensity_Normal_No.1,,0.5031976755689931
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,0.4969288086394488
RB2022_1_PostEndurance,,0.49898832528783943
CR2017_Ratio Replicate 3,,0.4957479348893662
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,0.5060686703627693
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,0.5056904900127518
HS2024_8_I_T3,,
CF2017_EOC 3,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,0.5001048660948
WZ2023_Pu_010_20min,0.6580923031573899,0.5186663004562956
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,,0.49963760084538444
RB2022_4_RecoveryEndurance,,0.4996581027034576
RB2022_5_RecoveryEndurance,,0.49699545903746145
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,0.5001602169912958
FSO2013_Ratio H/M normalized Rep2,,
RAM2015_Log2 A,,0.5006605836951181
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,0.5006792237722046
KS2014_Intensity E15_2,,0.4928526902685256
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,0.49357758731382584
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,0.4984912984950669
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,,0.5046883115489527
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,0.4951485082569684
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,0.4999901068094567
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,0.5003351990219176
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,,0.5087112204759635
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.5004872355527886
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,0.5010336489355938
AH2018_SILAC_IT_3_X,,0.5012934960913381
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,0.5035330294355843
FSO2013_Ratio M/L normalized Rep2,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,0.5086365331128279
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,
RB2022_6_PreSprint,,0.5036118135516716
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,0.4946941260973777
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,0.5007420673601153
DL2023_control-1,,
AR2021_ALG 10 μM,,0.5146676771359477
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,0.5032964013941842
EJN2021_4_Rest_Ins,,0.5002459345277276
RN2012_H05,,0.5025104374366133
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,0.49836773297655373
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,0.4993382262984669
EJN2021_1_Rest_Ins,,0.4994821839872531
HH2022_Reporter intensity 3,,0.49541127614025676
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,0.5015782324314169
JW2021_After_3,,
GF2025_P8_Sph,,0.5030449327108208
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,0.5011027177247545
CK2022_11 200-1,,0.483495854638394
CK2022_12 200-1,,0.4823016486675117
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,0.5061893921280307
WZ2023_Su_010_20min,0.6658363626100261,0.522140696078472
AH2018_TMTMS2_2_N,0.6588488591029786,0.49784419247687545
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,0.49585129005988104
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.4998343632266689
AH2018_TMTMS3_Pool,,0.49616503301625464
KS2014_Intensity N4,,0.49153022617485675
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,
CK2022_14 200-1,,0.4972911445787513
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,0.5018900804011099
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,0.4970022522226374
AST2020_anti-CD3+PDL2.2,,0.5004445406653729
PG2020_Intensity Mock_10h_A,,0.4924897126222165
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,0.4967545332407414
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,,0.4993460714195987
GF2025_P1_Sph,,0.5045468750036691
EJN2021_5_Ex_Basal,,0.5008434467471944
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.6528503208059678,0.5131068263515316
CF2017_EOC 1,,0.498725379372932
CK2022_3 200-1,,0.4910765260000274
AH2018_LFQ_IT_3_C,,0.5018420427398574
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,0.5034664454061478
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,0.49780478356102653
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,0.5018137175913181
CK2022_2 40-1,,
RB2022_1_PostSprint,,0.5000892569893415
CK2022_4 200-1,,0.490515746694869
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,,0.5268315883537007
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,0.4999154214734766
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,0.5028833274882092
CR2017_Ratio Replicate 3.2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,0.49397163615426143
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,,0.49775422217841503
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,0.48984688802443765
CK2022_16 16-1,,
FS2019_db/db3,,0.5015478124770882
CK2022_15 40-1,,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.657142200058913,0.5177110470029668
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,0.49578593032388185
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,0.49997344620044276
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,,0.4957413832465009
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,,0.5019343090650579
KBE2022_Log2_Ex_27_U,,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,,0.5006856655414731
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,0.4976170062070028
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,0.4987339836935582
YA2020_Reporter_intensity_Normal_No.4,,0.50365391774796
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,0.48404673995940095
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,,0.4962801518187158
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,0.5012541982772505
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,0.4919424076214994
CK2022_10 40-1,,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,0.5001687049735015
HH2022_Reporter intensity 6,,0.5043100301660345
RB2022_2_RecoveryStrength,,0.5003556510097255
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,0.4954700468008573
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,0.5008414686532113
AH2018_TMTMS2_3_X,0.659640585974149,0.4999542145613144
GF2025_P3_Adh,,0.49831248810127615
SR2019_JIMT1_Biol_repl_2,,0.500142198283621
AH2018_TMTMS2_1_C,0.6547149680841848,0.4979303477953017
RM2024_Intensity D0-1___2,,
LY2019_P4+,,0.5024630229236943
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,0.4999430393124099
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,0.5090679733936462
AST2020_Control,,0.4998989171248984
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,0.5018563718319987
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,0.5035478904449108
RB2022_7_RecoverySprint,,0.5030086864882662
YA2020_Reporter_intensity_Normal_No.3,,0.5053730478847333
HS2024_8_B_T2,,
AH2018_LFQ_1_X,,0.5013508523456585
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,0.5039649003764123
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,,0.4994060586682984
HH2022_Reporter intensity 1,,0.4952750213657568
HH2022_Reporter intensity 2,,0.49447797636431245
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,0.5033479472634889
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,,0.508348189168142
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,0.49732510251835427
CR2017_Ratio Replicate 2,,0.502971349373885
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,
AR2021_KD 72h,,0.4943695371448608
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,0.49505825312636004
KBE2022_Log2_Ex_9_U,,
AH2018_SILAC_M_3_N,,0.5050661839137539
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,0.5005764195709902
PG2020_Intensity Mock_10h_C,,0.488298560309071
CF2017_OSE 29,,0.5005653211091744
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,0.5036049361266083
RN2012_L12,,0.4983613945134275
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,0.5044793674798657
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,
RB2022_7_RecoveryEndurance,,0.503868074194866
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,0.5016824464326327
TM2022_S2.12h.B,,
RN2012_L15,,0.5001030345820084
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,0.500813220251417
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,0.4956960403617748
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,,0.49677843960726076
RB2022_1_PreSprint,,0.5013572186417494
HS2024_4_I_N1,,
CK2022_7 200-1,,0.4899216532641408
CK2022_5 200-1,,0.490423563223222
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,0.5029049432531687
AH2018_LFQ_2_C,,0.5008791139737158
AH2018_SILAC_MR_1_X,,0.5036798425551013
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,0.4990821080535581
AH2018_SILAC_3_C,,0.5044896622106924
EJN2021_5_Rest_Ins,,0.49924951450110255
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,0.4993162390707842
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,0.498178158520218
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,0.5012504239851714
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,0.4896734879180728
FSO2013_Ratio H/L normalized Rep3,,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,,
AH2018_SILAC_IT_2_N,,0.5028051502554822
AH2018_SILAC_IT_1_X,,0.5014452475348018
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,0.4921781340196549
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,0.5028455619873388
WZ2023_Pe_025_20min,0.6559398960103148,0.5154516115889912
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,0.49753015859476796
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.6590297946521904,0.4993187148102206
RN2012_H06,,0.4974568732679898
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.6571717462202121,0.5205495732841929
SR2019_HCC1419_Biol_repl_4,,0.49970025210998276
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,0.5007010949775461
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,0.4921436056551284
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,,0.48975939627674947
WZ2023_Su_025_10min,0.6640137214423338,0.5191983358972254
AH2018_LFQ_IT_4_X,,0.5043510369568045
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,0.5018834449072066
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.6571582583236071,0.5199029239098721
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,0.5021152576559856
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,,0.5004084672212723
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,0.5033706022488147
KS2014_Intensity,,0.4988467032709138
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,0.4941379395336513
LY2019_P7+,,0.5046195229748848
EP2017_Untreated R#1 normalized log2 ratio,,0.505879535595443
RN2012_L10,,0.4979755047813692
PG2020_Intensity 4h_C,,0.49383206495994736
EP2017_Mitotic R#3 normalized log2 ratio,,0.4973644480818835
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,0.49577328394445175
RB2022_8_PostStrength,,0.5029850891576056
AH2018_SILAC_IT_2_X,,0.500724210137069
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,,0.49466907185072123
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,0.4989856192420952
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,,0.49586293239696055
GF2025_P9_Sph,,0.5041024961744468
CK2022_6 200-1,,0.48997398505117484
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,0.4962604320787133
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,0.501001732054951
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,0.48782061949368755
EP2017_Untreated R#3 normalized log2 ratio,,0.48902321151196587
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,,0.4900467279269045
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,,
RB2022_7_PostEndurance,,0.4997623024675746
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,,0.5042769821264111
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,0.5018517779416836
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,0.5005296365590816
FR2021_Intensity.M,,
RB2022_2_PostSprint,,0.5020443895130909
AH2018_SILAC_MR_3_N,,0.5043503083982931
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,0.5013311117653153
PG2020_Intensity CT_C,,0.4967162881975014
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,0.4991594513209248
EP2017_Untreated R#3 log2 ratio,,0.48816686669754644
RB2022_2_PostStrength,,0.5018061210842788
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,,
HS2024_8_PD_T2,,
FS2019_Ctr2,,0.4991766537162365
RB2022_6_PreEndurance,,0.5010849713061332
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,0.49848961179191215
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,0.5003155681534645
CR2017_Ratio Replicate 2.3,,0.49663674089853976
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,0.49993672650977894
YA2020_Reporter_intensity_Normal_No.2,,0.5041457273493848
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,0.499121207167422
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,0.5008190324988496
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,,
RAM2015_Log2 B,,0.5026123377565592
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,0.5001061189793928
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,0.4909564586458916
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,,0.49926185480396396
WZ2023_Su_025_30min,0.6592669964890383,0.5209443680115324
AH2018_LFQ_4_N,,0.50326827994262
CR2017_Ratio Replicate 1.2,,0.49847132711734415
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,0.5024542939552152
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,0.5091988167092066
AH2018_SILAC_M_1_X,,0.5008764820622986
RB2022_7_PreEndurance,,0.5066630246227897
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,0.5017791482312564
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,0.4980620670563158
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,0.497331912405604
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,0.49600460744098135
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,0.5003195230921818
KS2014_Intensity C5,,0.4873405588946278
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,0.49992382317023376
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,0.49703322990694937
RB2022_3_PostStrength,,0.5016625153114223
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,0.49749837234785077
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,0.4915862531514834
AH2018_LFQ_2_X,,0.5001541257064
PG2020_Intensity 2h_B,,0.4952171676293877
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,0.5017319252879678
KS2014_Intensity E15_3,,0.4936602555226501
GF2025_P3_Sph,,0.4974221735477927
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,0.499608416928386
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,0.5031863036763846
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,0.5016096238197126
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,,
ZQ2022_N1,,
LY2019_P6-,,0.5006583605224282
RM2024_Intensity D2-3,,
UK2020_HCM_1,,0.491036229893636
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,0.5006702246224003
AH2018_LFQ_3_N,,0.5048233148033286
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,0.49219207566289463
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,0.5022932122664596
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,0.4947634246509623
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,0.5012595536655597
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.6635035343184749,0.5220996257594119
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,0.5033203392193679
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,0.49706499295193957
PG2020_Intensity 10h_D,,0.5044019564181809
RB2022_8_PreEndurance,,0.5007882750455479
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,0.5008970789734569
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,0.4990119802544242
EP2017_Pervanadate R#3 log2 ratio,,0.4953147822688073
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,0.4903993951551401
RB2022_6_PostStrength,,0.50311888481594
AH2018_SILAC_MR_3_C,,0.5042258505711028
AH2018_LFQ_M_4_C,,0.5010091418975363
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,0.5016464478796657
CK2022_6 40-1,,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,0.49663239903357487
LY2019_P3-,,0.5034238387731018
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,0.5003839724765632
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.6524061144599971,0.516102991087717
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,0.5012307349954948
AST2020_Control.1,,0.5003809531819976
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,
FS2019_Ctr3,,0.499090672223753
WZ2023_Pu_025_20min,0.6537437431254008,0.5210170534558611
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,0.4958508947895617
RB2022_1_RecoveryStrength,,0.5015602359717944
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.6572365130820013,0.4963791193616126
RB2022_4_PreSprint,,0.500163364134925
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,0.4978782886694095
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,0.49926407208597534
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,0.5010796466337202
LY2019_P8+,,0.5027523476437488
RB2022_2_RecoveryEndurance,,0.5012623267809952
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,0.5007013570306846
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,0.4971763548505557
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.501807133178723
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,0.5024197261226447
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,0.4978786510037184
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,0.5007719321087711
LY2019_P2-,,0.49884652794036927
AH2018_LFQ_IT_1_X,,0.5003043251491905
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,0.5023791858815094
WZ2023_Pe_005_20min,0.6528858245622524,0.5182743936232677
AST2020_Control.2,,0.4999655121959764
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,0.49449460313295646
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,0.5018780708307697
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,
AH2018_TMTMS3_3_N,,0.4952897699624068
SR2019_HCC1419_Biol_repl_2,,0.5002567476649129
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,0.5043184202635597
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,,0.4975309886528705
KBE2022_Log2_Ex_36_T,,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.6617489702460974,0.5202281287290803
KS2014_Intensity C2,,0.49191869364506235
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,0.49694900932006736
CK2022_9 200-1,,0.4820309498699059
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,0.48086247301820434
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,,0.49422312698669185
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,,
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,0.5013748494314497
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,0.5000210859819816
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,0.499371275530955
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,,0.5048515917784919
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.6577680412865966,0.5147913814395472
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,0.502425772947901
HS2024_5_I_T3,,
KS2014_Intensity N1,,0.5013748741365849
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,,0.4962089712675247
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,0.5044968902623544
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,0.4955973341048216
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,0.5037509737812358
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,0.49680317065315327
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,0.5008235722074764
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,,0.4892646629488622
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,0.4988935034185896
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,0.5001538149870489
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.6526201257117935,0.5166278772738183
KBE2022_Log2_Ex_29_U,,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,,0.5031242279319035
AH2018_LFQ_IT_4_N,,0.5049405134672962
CK2022_15 200-1,,0.49755066146037397
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,,0.49758608613210004
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,0.5008993405680664
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,,0.4889345467123286
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.6676087761807873,0.5240503652670135
RN2012_H01,,0.5017010610767543
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,0.49840671944220516
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,,0.5018145621025607
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,,0.5037167712961362
KBE2022_Log2_Ex_44_U,,0.498585154981657
WZ2023_Pe_010_20min,0.6535010037702345,0.5166056648959099
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,0.4957842612751708
RB2022_3_PreStrength,,0.4995073835976239
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,0.5026974270562031
KS2014_Intensity C1,,0.49508035280966944
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,,0.5046261491652739
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,0.5024634982202144
AH2018_SILAC_M_2_X,,0.49954932542044833
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,0.49856791856344074
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.6623481650996702,0.5237326717969333
PG2020_Intensity 6h_C,,0.4940906952121724
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,0.5036122928153605
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.6595618346215394,0.499183966517771
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,,0.5023668036943562
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,,0.4962279219227148
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,0.5008392159373904
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.5004310418898789
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,0.4925664356310484
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,,0.49513423760556263
EJN2021_2_Ex_Basal,,0.4987925606840963
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,0.5016326744376302
AR2021_L41 10 μM,,0.5201803714425061
CF2017_EOC 2,,
RB2022_6_PostEndurance,,0.4992448165622134
AH2018_SILAC_1_N,,0.5001553501589621
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,0.492581615467214
RB2022_7_PreSprint,,0.49932269454646905
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,,0.5037384395352081
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,0.4987677935223719
HH2022_Reporter intensity 0,,0.49474960716323546
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,0.5023489115785739
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.6583405127514336,0.49780185809125144
AR2021_L41 1 μM,,0.531152938835184
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.6572084240892379,0.4977166659742096
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,0.5044090390897285
KS2014_Intensity C4,,0.48494620476617095
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,0.5006556235042414
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,0.5040077887836618
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,0.5046239374197966
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,0.5006132698230876
AH2018_SILAC_IT_3_C,,0.501721837272978
WZ2023_Pu_025_10min,0.6534451464539675,0.5198651086870093
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,0.4990139792189446
FSO2013_Ratio M/L normalized Rep3___1,,
SR2019_JIMT1_Biol_repl_4,,0.4943187672292492
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.6552542463906509,0.5170434462712601
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,0.501063561042692
KS2014_Intensity C6,,0.5002578718443668
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,0.5041788162538813
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,
AH2018_SILAC_IT_2_C,,0.5018701444772209
CK2022_5 40-1,,
AH2018_LFQ_3_X,,0.5037687700193726
UK2020_UA_3,,0.4927661862494635
LY2019_P7-,,0.4962662622514319
GF2025_P5_Adh,,0.4986579045288059
RB2022_1_PostStrength,,0.5019414238997892
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,,0.504030154696279
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,,0.49891734688990097
PG2020_Intensity CT_B,,0.48578684459661164
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,0.5045147916039147
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,0.5013962592977309
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,0.5022202222133161
AH2018_LFQ_3_C,,0.5004294926323357
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,0.5068345992749845
YA2020_Reporter_intensity_Cancer_No.4,,0.5022534493160121
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,0.500929465276027
RB2022_2_PreEndurance,,0.5019547486004375
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,0.49842851955795964
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,,0.5002341770929314
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,0.5005458954970406
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,,0.495569826915537
AH2018_TMTMS2_1_X,0.6570607151890231,0.49732942475670494
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,0.500022497406173
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,0.5044820015052283
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,0.5036009811476336
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,0.5011755132127602
HS2024_4_I_T3,,
AH2018_SILAC_1_X,,0.5002990277478537
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,,0.4936930064389241
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,0.4934201276896717
SR2019_HCC1419_Biol_repl_3,,0.5006238817530824
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,,0.5092525960065952
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,0.49863963340160516
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,,0.5027804625599289
AS2011_Ratio H/L Normalized RNAi_2_1,,
